Opko Inc. has acquired Cytochroma Inc.

Target Company Name:
Country:
Advisory:
Sector:
Partner:
Cytochroma Inc.
Canada
Advisor
Healthcare & Pharmaceuticals
Crosbie & Company Inc.

Advised the Board and provided a fairness opinion relating to Opko Health's purchase of 100% of the shares of Cytochroma

Cytochroma Inc.
Opko Inc.
Advised the Board of Cytochroma and provided a fairness opinion relating to Opko's purchase the company
logo
Advisor :
Crosbie & Company Inc.

Experts who worked on this transaction

Colin Walker

Colin Walker

Managing Director at Crosbie & Company Inc.

Richard Betsalel

Richard Betsalel

Managing Director at Crosbie & Company Inc.

Relevant transactions

Transactions
Nordic Medcom
Physidia ASA
Nordic Medcom acquired by Physidia
logo
Advisor to the seller :
Aventum Partners
Akodoc
Corman
Acodok and Corman merged through an asset contribution into the newly established NewCo, ClickSalute
logo
Advisor :
Broletto Corporate Advisory
Apex Dental Lab
LongueVue Capital
Apex Dental Laboratory Group has completed a majority recapitalization with LongueVue Capital
logo
Advisor to the seller :
Brown Gibbons Lang & Company
Otofarma
Otofarma has successfully completed its listing on the Euronext Growth Milan market
logo
Advisor :
Broletto Corporate Advisory

REACH Cross-Border Mergers & Acquisitions is a worldwide partnership of 24 M&A advisory firms operating across 30 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2026 REACH Cross-Border Mergers & Acquisitions